column
China’s TB Portfolio for Advancing the 2030 End TB Goals
Shaojun Pei, Caihong Xu, Dongmei Hu, Yanlin Zhao
2026, 8(13): 367-373. DOI: 10.46234/ccdcw2026.059
Abstract FullText HTML PDF
Epidemiological Characteristics of Asymptomatic Tuberculosis — China, 2021–2024
Caihong Xu, Yaxin Wen, Yanlin Zhao, Biao Kan
2026, 8(13): 374-380. DOI: 10.46234/ccdcw2026.060
Abstract FullText HTML PDF
Scaling Up Tuberculosis Preventive Treatment: Progress and Factors Influencing Optimization — China, 2022–2025
Caihong Xu, Jinhao Li, Wen Yaxin, Dongmei Hu, Rongbin Yu, Yanlin Zhao
2026, 8(13): 381-386. DOI: 10.46234/ccdcw2026.061
Abstract FullText HTML PDF
Drug Resistance and Risk Factors of Bacteriologically Confirmed Tuberculosis Cases in 10 Sites — Hunan Province, China, 2018–2025
Jingwei Guo, Jun Liang, Yunhong Tan, Zuhui Xu, Baozhen Peng, Xichao Ou, Peilei Hu, Zhenhua Chen, Hua Bai, Binbin Liu, Wenjie Zhao, Liqin Liu, Yanhong Li, Xiaojie Wan, Jue Wang, Jie Duan, Yi Liu, Dehua Gong
2026, 8(13): 387-393. DOI: 10.46234/ccdcw2026.062
Abstract FullText HTML PDF
An Imported Case of Dengue/Zika Coinfection — Sichuan Province, China, 2026
Liwen Hu, Lyubo Tian, Ke Yan, Shuang Zhang, Wenjun Xie, Jing Feng, Xunbo Du, Liang Wang, Weixuan Liu, Junrong Luo, Fengzhu Tang, Ning Yang, Yao Wang, Yun Peng, Zhenhua Chen, Qing Zhang, Jiantong Meng, Rong Lu
2026, 8(13): 394-398. DOI: 10.46234/ccdcw2026.063
Abstract FullText HTML PDF